
New blood-based cancer screening tests must meet rigorous standards, including demonstrating a reduction in cancer-specific mortality, before being introduced as viable screening tools.


coremsg

Researchers warn that the test makers should not influence the design of the studies that evaluate these tests.

Do New Blood Tests for Cancer Meet the Right Standards?

evaluating-the-efficacy-and-regulatory-standards-of-new-blood-based-cancer-screening-tests


Evaluating the Efficacy and Regulatory Standards of New Blood-Based Cancer Screening Tests
